Skip to main content
SpringerLink
Log in

HIV Prevention, Care, and Treatment for Transgender Communities of Color

  • Chapter
  • First Online:
HIV in US Communities of Color

Abstract

Transgender communities of color face inequities in HIV prevalence, uptake of prevention interventions, and engagement in care and treatment. Intersecting oppression, i.e., racism, cissexism, transphobia, and HIV stigma, increases HIV vulnerability and reduces access to prevention and care services. Healthcare providers can facilitate care engagement by increasing their knowledge of transgender-specific healthcare issues and implementing gender-affirming care practices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Center of Excellence For Transgender Health DOFACM, University Of California San Francisco. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. San Francisco: University of California San Francisco; 2016. Available from: www.Transhealth.Ucsf.Edu/.

    Google Scholar 

  2. Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, et al. Transgender people: health at the margins of society. Lancet (London, England). 2016;388(10042):390–400.

    Article  Google Scholar 

  3. Labuski C, Keo-Meier C. The (Mis)Measure of Trans. TSQ. 2015;2(1):13–33.

    Article  Google Scholar 

  4. Glick JL, Theall K, Andrinopoulos K, Kendall C. For data’s sake: dilemmas in the measurement of gender minorities. Cult Health Sex. 2018;20:1362.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Reisner SL, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E, et al. Global health burden and needs of transgender populations: a review. Lancet (London, England). 2016;388(10042):412–36.

    Article  Google Scholar 

  6. Reisner SL, Radix A, Deutsch MB. Integrated and gender-affirming transgender clinical care and research. J Acquir Immune Defic Syndr (1999). 2016;72(Suppl 3):S235–42.

    Article  Google Scholar 

  7. Sevelius JM. Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color. Sex Roles. 2013;68(11–12):675–89.

    Article  PubMed  Google Scholar 

  8. Glynn TR, Gamarel KE, Kahler CW, Iwamoto M, Operario D, Nemoto T. The role of gender affirmation in psychological well-being among transgender women. Psychol Sex Orientat Gend Divers. 2016;3(3):336–44.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bauer GR, Scheim AI, Pyne J, Travers R, Hammond R. Intervenable factors associated with suicide risk in transgender persons: a respondent driven sampling study in Ontario, Canada. BMC Public Health. 2015;15:525.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mahfouda S, Moore JK, Siafarikas A, Hewitt T, Ganti U, Lin A, et al. Gender-affirming hormones and surgery in transgender children and adolescents. Lancet Diabetes Endocrinol. 2018;7:484.

    Article  PubMed  Google Scholar 

  11. Singer TB. The profusion of things: the “transgender matrix” and demographic imaginaries in US Public Health. TSQ. 2015;2(1):58–76.

    Article  Google Scholar 

  12. Meier SC, Labuski CM. The demographics of the transgender population. In: Baumle A, editor. The international handbook on the demography of sexuality. New York: Springer Press; 2013. p. 289–327.

    Chapter  Google Scholar 

  13. Wiepjes CM, Nota NM, De Blok CJM, Klaver M, De Vries ALC, Wensing-Kruger SA, et al. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): trends in prevalence, treatment, and regrets. J Sex Med. 2018;15:582.

    Article  PubMed  Google Scholar 

  14. Mcfarland W, Wilson E, Fisher RH. How many transgender men are there in San Francisco? J Urban Health. 2017;95:129.

    Article  PubMed Central  Google Scholar 

  15. Johnston LG, Prybylski D, Raymond H, Mirzazadeh A, Manopaiboon C, Mcfarland W. Incorporating the service multiplier method in respondent-driven sampling surveys to estimate the size of hidden and hard-to-reach populations: case studies from around the world. Sex Transm Dis. 2013;40(4):129.

    Article  Google Scholar 

  16. Yi SK, Steyvers M, Lee MD, Dry MJ. The wisdom of the crowd in combinatorial problems. Cogn Sci. 2012;36(3):452–70.

    Article  PubMed  Google Scholar 

  17. Tate CC, Ledbetter JN, Youssef CP. A two-question method for assessing gender categories in the social and medical sciences. J Sex Res. 2013;50(8):767–76.

    Article  PubMed  Google Scholar 

  18. Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2nd ed. San Francisco: University of California, San Francisco, Department of Family and Community Medicine Center of Excellence for Transgender Health; 2016. p. 199.

    Google Scholar 

  19. The Geniuss Group. In: Herman J, editor. Best practices for asking questions to identify transgender and other gender minority respondents on population-based surveys. Los Angeles: The Williams Institute; 2014.

    Google Scholar 

  20. Hughto JMW, Reisner SL, Pachankis JE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015;147:222–31.

    Article  Google Scholar 

  21. Thompson HM. Patient perspectives on gender identity data collection in electronic health records: an analysis of disclosure, privacy, and access to care. Transgend Health. 2016;1(1):205–15.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ingraham N, Pratt V, Gorton N. Counting trans∗ patients: a Community Health Center case study. TSQ. 2015;2(1):136–47.

    Article  Google Scholar 

  23. Arnold EA, Sterrett-Hong E, Jonas A, Pollack LM. Social networks and social support among ball-attending African American men who have sex with men and transgender women are associated with HIV-related outcomes. Glob Public Health. 2018;13(2):144–58.

    Article  PubMed  Google Scholar 

  24. Flores AR, Herman JL, Gates GJ, Brown TNT. How many adults identify as transgender in the United States? Los Angeles: The Williams Institute; 2016. [Cited 2017 June 30]. Available From: Http://Williamsinstitute.Law.Ucla.Edu/Wp-Content/Uploads/How-Many-Adults-Identify-As-Transgender-In-The-United-States.Pdf.

    Google Scholar 

  25. Herman JL, Flores AR, Brown TN, Wilson BD, Conron KJ. Age of individuals who identify as transgender in the United States. Los Angeles: The Williams Institute; 2017.

    Google Scholar 

  26. Flores AR, Brown TN, Herman J. Race and ethnicity of adults who identify as transgender in the United States. Los Angeles: Williams Institute, UCLA School of Law; 2016.

    Google Scholar 

  27. James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. transgender survey. Washington, D.C.: National Center For Transgender Equality; 2016.

    Google Scholar 

  28. Meerwijk EL, Sevelius JM. Transgender population size in the United States: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):E1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006-2017. Am J Public Health. 2019;109(1):e1‐e8. https://doi.org/10.2105/AJPH.2018.304727.

  30. Clark H, Babu AS, Wiewel EW, Opoku J, Crepaz N. Diagnosed HIV infection in transgender adults and adolescents: results from the National HIV Surveillance System, 2009-2014. AIDS Behav. 2016;21:2774.

    Article  Google Scholar 

  31. Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI, et al. Revised surveillance case definition for HIV infection—United States, 2014. MMWR Recomm Rep. 2014;63(3):1–10.

    Google Scholar 

  32. Health Resources and Services Administration. Ryan White HIV/AIDS program annual client-level data report 2017. Published 2018 [Updated December 2018; Cited 15 December 2018]. Available from: Http://Hab.Hrsa.Gov/Data/Data-Reports.

  33. Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS (London, England). 2017;31(5):731–4.

    Article  Google Scholar 

  34. Calabrese SK. Interpreting gaps along the preexposure prophylaxis cascade and addressing vulnerabilities to stigma. Am J Public Health. 2018;108(10):1284–6.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to prep acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248–54.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Grant RM, Anderson PL, Mcmahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Poteat T, German D, Flynn C. The conflation of gender and sex: gaps and opportunities in HIV data among transgender women and MSM. Glob Public Health. 2016;11(7–8):835–48.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (Prep) and interest in using Prep among black and white men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236–46.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Garnett M, Hirsch-Moverman Y, Franks J, Hayes-Larson E, El-Sadr WM, Mannheimer S. Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York City. AIDS Care. 2018;30(1):9–17.

    Article  PubMed  Google Scholar 

  40. Jalil EM, Grinsztejn B, Velasque L, Ramos Makkeda A, Luz PM, Moreira RI, et al. Awareness, willingness, and prep eligibility among transgender women in Rio De Janeiro, Brazil. J Acquir Immune Defic Syndr (1999). 2018;79(4):445–52.

    Article  Google Scholar 

  41. Oldenburg CE, Le B, Toan T, Thien DD, Huyen HT, Friedman MR, et al. HIV pre-exposure prophylaxis indication and readiness among HIV-uninfected transgender women in Ho Chi Minh City, Vietnam. AIDS Behav. 2016;20(Suppl 3):365–70.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Wang Z, Lau JTF, Yang X, Cai Y, Gross DL, Ma T, et al. Acceptability of daily use of free oral pre-exposure prophylaxis (prep) among transgender women sex workers in Shenyang, China. AIDS Behav. 2017;21(12):3287–98.

    Article  PubMed  Google Scholar 

  43. Zalazar V, Aristegui I, Kerr T, Marshall BDL, Romero M, Sued O, et al. High willingness to use HIV pre-exposure prophylaxis among transgender women in Argentina. Transgend Health. 2016;1(1):266–73.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Restar AJ, Kuhns L, Reisner SL, Ogunbajo A, Garofalo R, Mimiaga MJ. Acceptability of antiretroviral pre-exposure prophylaxis from a cohort of sexually experienced young transgender women in two U.S. cities. AIDS Behav. 2018;22:3649.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Rael C, Martinez M, Giguere R, Bockting W, Maccrate C, Mellman W, et al. Barriers and facilitators to oral Prep use among transgender women in New York City. AIDS Behav. 2018;22(11):3627–36.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Kuhns LM, Reisner SL, Mimiaga MJ, Gayles T, Shelendich M, Garofalo R. Correlates of Prep indication in a multi-site cohort of young HIV-uninfected transgender women. AIDS Behav. 2016;20(7):1470–7.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to Prep acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75.

    Article  PubMed  Google Scholar 

  48. Poteat T, Wirtz A, Malik M, Cooney E, Cannon C, Hardy WD, et al. A gap between willingness and uptake: findings from mixed methods research on HIV prevention among Black and Latina transgender women. J Acquir Immune Defic Syndr (1999). 2019;82(2):131–40.

    Article  Google Scholar 

  49. Brooks RA, Cabral A, Nieto O, Fehrenbacher A, Landrian A. Experiences of pre-exposure prophylaxis stigma, social support, and information dissemination among Black and Latina transgender women who are using pre-exposure prophylaxis. Transgend Health. 2019;4(1):188–96.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Poteat T, Wirtz AL, Reisner S. Strategies for engaging transgender populations in HIV prevention and care. Curr Opin HIV AIDS. 2019;14(5):393–400.

    Article  PubMed  Google Scholar 

  51. Beckwith CG, Kuo I, Fredericksen RJ, Brinkley-Rubinstein L, Cunningham WE, Springer SA, et al. Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: data from the seek, test, treat, and retain harmonization initiative. Plos One. 2018;13(5):E0197730.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Poteat T, Hanna DB, Rebeiro PF, Klein M, Silverberg MJ, Eron JJ, et al. Characterizing the human immunodeficiency virus care continuum among transgender women and cisgender women and men in clinical care: a retrospective time-series analysis. Clin Infect Dis. 2019;70(6):1131–8.

    Article  PubMed Central  Google Scholar 

  53. Kalichman SC, Hernandez D, Finneran S, Price D, Driver R. Transgender women and HIV-related health disparities: falling off the HIV treatment cascade. Sex Health. 2017;14(5):469–76.

    Article  PubMed  Google Scholar 

  54. Mizuno Y, Frazier E, Huang P, Skarbinski J. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health. 2015;2:228.

    Article  PubMed  Google Scholar 

  55. Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014;90(5):430–3.

    Article  PubMed  Google Scholar 

  56. Baguso GN, Gay CL, Lee KA. Medication adherence among transgender women living with HIV. AIDS Care. 2016;28(8):976–81.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Mizuno Y, Beer L, Huang P, Frazier EL. Factors associated with antiretroviral therapy adherence among transgender women receiving HIV medical care in the United States. LGBT Health. 2017;4:181.

    Article  PubMed  Google Scholar 

  58. Machtinger EL, Haberer JE, Wilson TC, Weiss DS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav. 2012;16(8):2160–70.

    Article  CAS  PubMed  Google Scholar 

  59. Poteat T, German D, Kerrigan D. Managing uncertainty: a grounded theory of stigma in transgender health care encounters. Soc Sci Med (1982). 2013;84:22–9.

    Article  Google Scholar 

  60. Dowshen N, Lee S, Franklin J, Castillo M, Barg F. Access to medical and mental health services across the HIV care continuum among young transgender women: a qualitative study. Transgend Health. 2017;2(1):81–90.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care. 2010;21(3):256–64.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.

    Article  PubMed  Google Scholar 

  63. Chung C, Kalra A, Mcbride B, Roebuck C, Sprague L. Some kind of strength: findings on health care and economic wellbeing from a national needs assessment of transgender and gender non-conforming people living with HIV. Oakland: Transgender Law Center; 2016.

    Google Scholar 

  64. Braun HM, Candelario J, Hanlon CL, Segura ER, Clark JL, Currier JS, et al. Transgender women living with HIV frequently take antiretroviral therapy and/or feminizing hormone therapy differently than prescribed due to drug-drug interaction concerns. LGBT Health. 2017;4(5):371–5.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Rosen JG, Malik M, Cooney EE, Wirtz AL, Yamanis T, Lujan M, et al. Antiretroviral treatment interruptions among Black and Latina transgender women living with HIV: characterizing co-occurring, multilevel factors using the gender affirmation framework. AIDS Behav. 2019;23:2588.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Crosby RA, Salazar LF, Hill BJ. Correlates of not using antiretroviral therapy among transwomen living with HIV: the unique role of personal competence. Transgend Health. 2018;3(1):141–6.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014;26(8):976–82.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Cunningham WE, Weiss RE, Nakazono T, Malek MA, Shoptaw SJ, Ettner SL, et al. Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail: the link La randomized clinical trial. JAMA Intern Med. 2018;178(4):542–53.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Sevelius JM, Fau PE, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16. (1532-4796 (Electronic)).

    Article  PubMed  Google Scholar 

  70. Jaffee KD, Shires DA, Stroumsa D. Discrimination and delayed health care among transgender women and men: implications for improving medical education and health care delivery. Med Care. 2016;54:1010.

    Article  PubMed  Google Scholar 

  71. Shipherd JC, Green KE, Abramovitz S. Transgender clients: identifying and minimizing barriers to mental health treatment. J Gay Lesbian Mental Health. 2010;14(2):94–108.

    Article  Google Scholar 

  72. Shires DA, Jaffee K. Factors associated with health care discrimination experiences among a national sample of female-to-male transgender individuals. Health Soc Work. 2015;40(2):134–41.

    Article  PubMed  Google Scholar 

  73. Sperber J, Landers S, Lawrence S. Access to health care for transgendered persons: results of a needs assessment in Boston. Int J Transgend. 2005;8(2–3):75–91.

    Article  Google Scholar 

  74. Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, et al. Behavioral and health outcomes for HIV+ young transgender women (YTW) linked to and engaged in medical care. LGBT Health. 2016;3(2):162–7.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Cahill S, Singal R, Grasso C, King D, Mayer K, Baker K, et al. Do ask, do tell: high levels of acceptability by patients of routine collection of sexual orientation and gender identity data in four diverse American Community Health Centers. PLoS One. 2014;9(9):E107104.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Radix AE, Lelutiu-Weinberger C, Gamarel KE. Satisfaction and healthcare utilization of transgender and gender non-conforming individuals in Nyc: a community-based participatory study. LGBT Health. 2014;1(4):302–8.

    Article  PubMed  Google Scholar 

  77. Safer JD, Tangpricha V. Care of the transgender patient. Ann Intern Med. 2019;171(1):Itc1–Itc16.

    Google Scholar 

  78. Eriksson SE, Safer JD. Evidence-based curricular content improves student knowledge and changes attitudes towards transgender medicine. Endocr Pract. 2016;22(7):837–41.

    Article  PubMed  Google Scholar 

  79. Safer JD, Pearce EN. A simple curriculum content change increased medical student comfort with transgender medicine. Endocr Pract. 2013;19(4):633–7.

    Article  PubMed  Google Scholar 

  80. Vance SR Jr, Deutsch MB, Rosenthal SM, Buckelew SM. Enhancing pediatric trainees’ and students’ knowledge in providing care to transgender youth. J Adolesc Health. 2017;60(4):425–30.

    Article  PubMed  Google Scholar 

  81. Radix A, Maingi S. LGBT cultural competence and interventions to help oncology nurses and other health care providers. Semin Oncol Nurs. 2018;34(1):80–9.

    Article  PubMed  Google Scholar 

  82. Lelutiu-Weinberger C, Pollard-Thomas P, Pagano W, Levitt N, Lopez EI, Golub SA, et al. Implementation and evaluation of a pilot training to improve transgender competency among medical staff in an urban clinic. Transgend Health. 2016;1(1):45–53.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Stroumsa D, Shires DA, Richardson CR, Jaffee KD, Woodford MR. Transphobia rather than education predicts provider knowledge of transgender health care. Med Educ. 2019;53(4):398–407.

    Article  PubMed  Google Scholar 

  84. Braun HM, Garcia-Grossman IR, Quinones-Rivera A, Deutsch MB. Outcome and impact evaluation of a transgender health course for health profession students. LGBT Health. 2017;4(1):55–61.

    Article  PubMed  Google Scholar 

  85. Lungu E, Thibault-Lemyre A, Dominguez JM, Trudel D, Bureau NJ. A case of recurrent leg necrotic ulcers secondary to silicone migration in a transgender patient: radiographic, ultrasound and MRI findings. BJR Case Rep. 2016;2(1):20150309.

    PubMed  PubMed Central  Google Scholar 

  86. Leonardi NR, Compoginis JM, Luce EA. Illicit cosmetic silicone injection: a recent reiteration of history. Ann Plast Surg. 2016;77(4):485–90.

    Article  CAS  PubMed  Google Scholar 

  87. Agrawal N, Altiner S, Mezitis NH, Helbig S. Silicone-induced granuloma after injection for cosmetic purposes: a rare entity of calcitriol-mediated Hypercalcemia. Case Rep Med. 2013;2013:807292.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Soeroso NN, Rhinsilva E, Soeroso L. Acute pneumonitis following breast silicone liquid injection. Respirol Case Rep. 2018;6(6):E00335.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Poteat T, Wirtz AL, Radix A, Borquez A, Silva-Santisteban A, Deutsch MB, et al. HIV risk and preventive interventions in transgender women sex workers. Lancet (London, England). 2015;385(9964):274–86.

    Article  Google Scholar 

  90. Nuttbrock LA, Hwahng SJ. Ethnicity, sex work, and incident HIV/STI among transgender women in New York City: a three year prospective study. AIDS Behav. 2017;21(12):3328–35.

    Article  PubMed  Google Scholar 

  91. Newcomb ME, Hill R, Buehler K, Ryan DT, Whitton SW, Mustanski B. High burden of mental health problems, substance use, violence, and related psychosocial factors in transgender, non-binary, and gender diverse youth and young adults. Arch Sex Behav. 2019;49:645.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Murchison GR, Agenor M, Reisner SL, Watson RJ. School restroom and locker room restrictions and sexual assault risk among transgender youth. Pediatrics. 2019;143(6):e20182902.

    Article  PubMed  Google Scholar 

  93. Griner SB, Vamos CA, Thompson EL, Logan R, Vázquez-Otero C, Daley EM. The Intersection of Gender Identity and Violence: Victimization Experienced by Transgender College Students [published online ahead of print, 2017 Aug 1]. J Interpers Violence. 2017;886260517723743. doi:10.1177/0886260517723743

    Google Scholar 

  94. Birkhoff EM, Krouwel EM, Nicolai MP, De Boer BJ, Beck JJ, Putter H, et al. Dealing with patients facing a history of sexual abuse: a cross-sectional survey among Dutch general practitioners. Eur J Gen Pract. 2016;22(2):126–33.

    Article  PubMed  Google Scholar 

  95. Centers for Disease Control and Prevention (CDC). Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60(3):65–8.

    Google Scholar 

  96. US Preventive Services Task Force. Preexposure prophylaxis for the prevention of HIV infection: US Preventive Services Task Force recommendation statement. JAMA. 2019;321(22):2203–13.

    Article  Google Scholar 

  97. Centers for Disease Control and Prevention. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: A clinical practice guideline. 2018. Available at https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Accessed June 3, 2020.

  98. Deutsch MB, Glidden DV, Sevelius J, Keatley J, Mcmahan V, Guanira J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iprex trial. Lancet HIV. 2015;2(12):e512–9.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Mehrotra ML, Westreich D, Mcmahan VM, Glymour MM, Geng E, Grant RM, et al. Baseline characteristics explain differences in effectiveness of randomization to daily oral TDF/FTC prep between transgender women and cisgender men who have sex with men in the iprex trial. J Acquir Immune Defic Syndr (1999). 2019;81(3):E94.

    Article  Google Scholar 

  100. Hiransuthikul A, Janamnuaysook R, Himmad K, Kerr SJ, Thammajaruk N, Pankam T, et al. Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the ifact study. J Int AIDS Soc. 2019;22(7):E25338.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Cottrell ML, HMA P, Schauer AP, Sykes C, Maffuid K, Poliseno A, et al. Decreased tenofovir diphosphate concentrations in a transgender female cohort: implications for HIV pre-exposure prophylaxis (prep). Clin Infect Dis. 2019;69:2201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Wood SM, Lee S, Barg FK, Castillo M, Dowshen N. Young transgender women’s attitudes toward HIV pre-exposure prophylaxis. J Adolesc Health. 2017;60(5):549–55.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed June 3, 2020. 

  104. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society∗ Clinical practice guideline. J Clin Endocrinol Metabol. 2017;102(11):3869–903.

    Article  Google Scholar 

  105. Radix A, Sevelius J, Deutsch MB. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc. 2016;19(3 Suppl 2):20810.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Van Caenegem E, Taes Y, Wierckx K, Vandewalle S, Toye K, Kaufman JM, et al. Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone. 2013;54(1):92–7.

    Article  PubMed  Google Scholar 

  107. Radix A, Deutsch MB. Bone health and osteoporosis. In: Deutsch MB, editor. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2nd ed. San Francisco: Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California San Francisco; 2016.

    Google Scholar 

  108. Light A, Wang LF, Zeymo A, Gomez-Lobo V. Family planning and contraception use in transgender men. Contraception. 2018;98(4):266–9.

    Article  PubMed  Google Scholar 

  109. Department Of Health And Human Services. Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States 2018. Available from: Https://Aidsinfo.Nih.Gov/Guidelines/Html/3/Perinatal-Guidelines/0.

Download references

Author information

Authors and Affiliations

  1. Department of Social Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC, USA

    Tonia Poteat

  2. Callen-Lorde Community Health Center, New York, NY, USA

    Asa E. Radix

Authors
  1. Tonia Poteat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asa E. Radix
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tonia Poteat .

Editor information

Editors and Affiliations

  1. Division of Global Health Equity, Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital Harvard Medical School, Boston, MA, USA

    Bisola O. Ojikutu

  2. Division of General Internal Medicine, Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital Harvard Medical School, Boston, MA, USA

    Valerie E. Stone

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Poteat, T., Radix, A.E. (2021). HIV Prevention, Care, and Treatment for Transgender Communities of Color. In: Ojikutu, B., Stone, V. (eds) HIV in US Communities of Color. Springer, Cham. https://doi.org/10.1007/978-3-030-48744-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48744-7_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48743-0

  • Online ISBN: 978-3-030-48744-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation